GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling for the US government to support increased investments in tuberculosis (TB) R&D, improved coordination through global platforms, and streamlined processes for adding new tools to essential product lists and releasing treatment guidelines.
News & Insights
Check out the latest news and announcements from GHTC.
GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling on the US government to help strengthen implementation of recommendations from the World Health Organization’s expert body on immunization, accelerate the R&D agenda to advance next-generation COVID-19 vaccines, and support research on the full spectrum of needed immunization innovations, including vaccine administration tools and storage and delivery innovations.
- In the media
Latest from the Breakthroughs Blog
Read stories about bright ideas and bold innovations in global health.
Research Roundup: A chikungunya vaccine trial, COVID-19 challenge study, and long-acting HIV treatment
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Learn more about upcoming events hosted by or featuring GHTC and its members.
Achieving health for all and meeting the Sustainable Development Goals through inclusive research and development and equitable access: Best practices and lessons learned
Drugs for Neglected Diseases initiative, Medicines for Malaria Venture, and TB Alliance
Washington Global Health Alliance
Infectious Diseases Society of America, The Society for Healthcare Epidemiology of America, HIV Medicine Association, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
American Society of Tropical Medicine & Hygiene
- GHTC event